AI and genetics are creating a ‘seismic shift’ in the pharmaceutical business, experts on Asian Financial Forum panel say.
While the U.S. chases breakthroughs, China is betting on scale, speed, and real-world adoption—and that may prove decisive in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results